Lifecall is paving the way in digital health with its innovative mobile application that cleverly embeds EKG technology, allowing users to monitor their heart health with ease. Founded in 2014, the company sits at the intersection of Consumer Electronics and Healthtech, focusing on revolutionizing the way health monitoring and diagnostics are conducted outside traditional clinical settings. The app makes heart health management accessible to tech-savvy consumers seeking wellness solutions from the convenience of their smartphones.
Having received a €71.43K grant investment on 01 March 2018 from EASME - EU Executive Agency for SMEs, Lifecall shows promise in scaling its technology and reaching a broader audience. While specific headquarters information isn't available, their engagement with a recognized EU agency underscores potential trust and credibility within the industry. For venture capitalists, Lifecall represents an intriguing opportunity to invest in a burgeoning digital health market, leveraging innovative technology to transform personal health management.
